Author(s): Alison Perlberg
Mentor(s): Dr. Jane Flinn, Psychology
Abstract
Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder that is characterized by the development of tau tangles within neurons, resulting in impairments in cognition and memory. As increased levels of oxidative stress are seen early in the disease and could activate various pathways that result in further AD development, a measure of oxidative stress, superoxide dismutase (SOD), was chosen as the enzyme of interest. In order to counteract these impairments, four-month-old transgenic (Tg, 4510 hTau) and wildtype (Wt) mice were treated with either plasma or saline. Mice were injected with plasma drawn from young, healthy mice over the course of seven treatments. Saline injections acted as a control. To determine if these treatments were effective in reversing AD side effects in the transgenic mice, we performed western blot analysis (n = 4 for each group) to compare concentrations of SOD. Western blot analyses were run with an Oxidative Stress cocktail. Data was analyzed through a two-way ANOVA and analysis of the western blots identified that there were, surprisingly, not significant differences between concentrations of SOD within the brains of Tg mice treated with plasma and the brains of Tg mice treated with saline, as the AD mice did not appear to have existing significantly high measures of oxidative stress. However, plasma injections of the Wt mice showed a significant trend of reduction of SOD when compared to the Wt mice that received saline injections. While plasma injections into Tg mice did not appear to decrease measures of oxidative stress, plasma injections of Wt mice may indicate the potential to use plasma injections to reduce AD pathways and mitigate AD impairments.
Hello, my name is Alison Perlberg, and under the direction of Dr. Flinn of the psychology department, this is my presentation on the So to start, what is Alzheimer’s disease? Alzheimer’s disease, shortened to AD, is a neurdegenerative disease that is characterized by a decline in cognitive and behavioral abilities, such as memory and learning. One of the hallmark AD pathologies that occur in the brain are tau tangles. Inside neurons, tau tangles are small fiber clumps that are made of a protein called tau and form when tau proteins abnormally clump together, creating neurofibrillary tangles. When these tangles form in the neuron, the neuron is blocked from receiving nutrients and sending out signals, and eventually dies. Possible explanations for why these tangles form is if there is an increased concentration of vasopressin, a hormone, or oxidative stress in the brain. One of the best methods for monitoring and researching these pathologies are through genetically modified mouse models. These transgenic mice carry a human gene for AD, which allows us to study AD in action in a model that is more ethical, safer, and easier to test than it would be in humans. Our method for attempting to decrease the concentrations of vasopressin and oxidative stress in the mice was through administered injections of plasma collected from young mice. Hernandez et al. found that when aged AD mice were given transfusions of plasma from young mice, the plasma appeared to have properties that decreased the development of the tau tangles. However, they were unable to rescue any cognitive or behavioral impairments. The study done by Hernandez et al. served as the basis for this current study, and is built off the same principles. Once our mice had undergone seven rounds of injections and had finished their behavioral trials, I was then able to go through and analyze the concentration of measures of oxidative stress and vasopressin in their brains through western blot analysis. So what are SOD and vasopressin? Superoxide dismutase, or SOD, is a measure of oxidative stress, and was the measure of focus for oxidative stress in this study. In a transgenic mouse model study done in 2019, the researchers found that increased levels of oxidative stress activated a chemical pathway in the brain that resulted in the development of more tau, and thusly more tau tangles. Vasopressin is a hormone that occurs naturally in the pituitary gland in the brain and, in mice, is important for nesting abilities. Nesting is an innate behavior found in mice, but AD mice often have impaired nesting abilities. Craven et al. actually found that mice that had higher concentrations of vasopressin tended to build poorer nests than mice with normal levels of vasopressin. Because of this, there likely is a correlation with AD and high levels of vasopressin. In order to run the western blot analysis, the brain samples from the mice were emulsified into a liquid, and the mixed with phosphate buffered saline (PBS), LDS sample buffer, and a reducing agent. These mixtures were then pipetted into a gel to undergo electrophoresis. Following completion of the electrophoresis, while invisible at this point to the naked eye, the proteins from the sample had traveled down the gel and were dispersed by weight. In order to visualize these weights, the gel image was transferred to a blotting paper through the iBlot machine. The paper was then incubated overnight with the primary antibody, an oxidative stress defense cocktail, and the secondary antibody, goat anti-rabbit IgG. After the incubation period, the blot Evaluation of young mouse plasma transfusion efficacy in a mouse model of Alzheimer’s Disease through Western Blot analysis paper was imaged through an imagining machine, visualizing the protein concentrations for data analysis. At the start of the study, the anticipated outcome was that the AD mice who received plasma injections would show decreased concentrations of SOD and vasopressin in the brain compared to AD mice who were injected with just saline. However, I wasn’t able to run enough vasopressin westerns to have analyzable data, and I wasn’t able to obtain a new bottle of vasopressin antibodies in time. Once the antibodies are delivered, I will look into different methods for looking at vasopressin, as western blot may not be the most effective approach for this hormone. In the oxidative stress study, there did not appear to be any significant difference between the experimental and control groups. In order for data to be significant, its p-value must be less than 0.05 when run through statistical analysis. The results from the oxidative stress demonstrated a p-value of 0.524. This value is larger than 0.05, and is therefore deemed insignificant. This large of a p-value indicates that the experimental and control groups were too similar and had very little difference between them, meaning the plasma was not effective at lowering SOD concentrations in AD mice. A possible explanation for why this data is so insignificant is that the plasma was injected into the mice too late in life for it to be effective. Interestingly enough, with a p-value of 0.098, I did get significantly trending results when the wildtype mice were injected with plasma. Wildtype mice that received the plasma injections actually had lower concentrations of SOD than their saline counterparts. Because of these results, I’ll actually be re-running these tests on a separate cohort of mice who are much younger at two-months-old, as four-month-old mice may be too advanced for the plasma to be effective. I’d like to thank Dr. Flinn for her mentorship, Rachel Barkey and Karin Pedemonte for their support and guidance, , to the Krasnow institute for providing the equipment, chemicals, and space needed to conduct this research, and to OSCAR for funding this study. Thank you!